115 related articles for article (PubMed ID: 17374229)
1. [Clonality analysis of multifocal bladder tumors].
Zhang SB; Zhang YP; Liu LN; Zhang YN; Huang SF; Cheng L
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):5-6. PubMed ID: 17374229
[No Abstract] [Full Text] [Related]
2. Allelic losses demonstrate monoclonality of multifocal bladder tumors.
Louhelainen J; Wijkström H; Hemminki K
Int J Cancer; 2000 Aug; 87(4):522-7. PubMed ID: 10918192
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.
Cheng L; Jones TD; McCarthy RP; Eble JN; Wang M; MacLennan GT; Lopez-Beltran A; Yang XJ; Koch MO; Zhang S; Pan CX; Baldridge LA
Am J Pathol; 2005 May; 166(5):1533-9. PubMed ID: 15855652
[TBL] [Abstract][Full Text] [Related]
4. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
5. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
6. Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ.
Gaisa NT; Tilki D; Losen I; Dahl E; Stoehr R; Stief CG; Knüchel R
Hum Pathol; 2008 Aug; 39(8):1258-62. PubMed ID: 18547617
[TBL] [Abstract][Full Text] [Related]
7. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
[TBL] [Abstract][Full Text] [Related]
8. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
10. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
Chow NH; Cairns P; Eisenberger CF; Schoenberg MP; Taylor DC; Epstein JI; Sidransky D
Int J Cancer; 2000 Nov; 89(6):514-8. PubMed ID: 11102896
[TBL] [Abstract][Full Text] [Related]
11. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
[TBL] [Abstract][Full Text] [Related]
12. New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder.
Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
Anticancer Res; 2004; 24(3a):1733-6. PubMed ID: 15274348
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
14. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
15. Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer.
von Knobloch R; Bugert P; Jauch A; Kälble T; Kovacs G
J Pathol; 2000 Feb; 190(2):163-8. PubMed ID: 10657014
[TBL] [Abstract][Full Text] [Related]
16. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.
Natrajan R; Louhelainen J; Williams S; Laye J; Knowles MA
Cancer Res; 2003 Nov; 63(22):7657-62. PubMed ID: 14633686
[TBL] [Abstract][Full Text] [Related]
17. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
[TBL] [Abstract][Full Text] [Related]
18. Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.
Priemer DS; Wang M; Zhang S; Lopez-Beltran A; Kouba E; Montironi R; Davidson DD; MacLennan GT; Wang L; Osunkoya AO; Deng Y; Emerson RE; Cheng L
Eur Urol Focus; 2018 Dec; 4(6):880-888. PubMed ID: 28753872
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking.
Uchida T; Wang C; Wada C; Iwamura M; Egawa S; Koshiba K
Int J Cancer; 1996 Apr; 69(2):142-5. PubMed ID: 8608983
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]